MicroRNA-495 Confers Increased Sensitivity to Chemotherapeutic Agents in Gastric Cancer via the Mammalian Target of Rapamycin (mTOR) Signaling Pathway by Interacting with Human Epidermal Growth Factor Receptor 2 (ERBB2)

BACKGROUND: In recent years, the incidence of gastric cancer (GC) has been increasing worldwide. Emerging evidence shows that microRNAs (miRs) may be involved in the pathogenesis of GC. Thus, this study explored the mediatory role of miR-495 in GC chemosensitivity, and investigated the mechanism by...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Med Sci Monit
Hlavní autoři: Li, Na, Han, Mei, Zhou, Ning, Tang, Yong, Tang, Xu-Shan
Médium: Artigo
Jazyk:Inglês
Vydáno: International Scientific Literature, Inc. 2018
Témata:
Clinical Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6122272/
https://ncbi.nlm.nih.gov/pubmed/30147110
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12659/MSM.909458
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky